Accrol Group Holdings PLC Q&A with Mike Allen Head of Research at Zeus Capital (LON:ACRL)

Accrol Group Holdings plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Accrol Group Holdings PLC (LON:ACRL) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview

 

Q1: Now, Accrol Group issued a trading statement today, what’s your view on the statement?

A1: So, I think in terms of the trading update, they confirmed that they’re performing in line with market expectations for the year to 30th April 2017, we think that during the periods of higher inflation more consumers will move into the discount sector and private label products and I think Accrol Group is very well positioned there. So, we think the business is well positioned for future growth and they managed their FX exposure very well during the year via hedging arrangements as well so yes, I think they’re performing well and are well positioned for the future.

 

Q2: So, what can you tell me about your forecast assumptions?

A2: We’re maintaining our forecast assumptions for now but we are expecting double digit revenue growth through to 2019 on fairly flat margin assumptions which should translate into 20% earnings growth for the next couple of years, strong cash generation we’re expecting as well to pay down most of the debt that they had from IPO in 2019. I think based on these assumptions the return on capital should be approaching 20% by 2019 as well and it’s also backed by a very strong free cash flow yield of 8-10% so they’re ticking a lot of boxes in terms of growth, cash generation and unique market positioning.

 

Q3: What your view on the stock’s valuation at the moment for Accrol Group Holdings?

A3: I think with the 2017 numbers essentially delivered, as we look into 2018 and 2019 the PE is on less than 12 times 2018 to April, falling to 10 times in 2019, the dividend yield is about 4% and growing progressively and the EV EBITDA is sub-9 times so I think keep given the cash generation and rising return on capital profile, I think with the valuation still looks reasonable to us given how they’ve chose to perform this year as well.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Accrol Group Holdings plc (LON:ACRL) has announced the publication of a shareholder circular detailing terms of the Scheme. Learn more here.
Discover the latest results and overview of Accrol Group Holdings, the UK's top independent tissue converter, led by CEO Gareth Jenkins and CFO Chris Welsh.
In this interview, Gervais Williams, co-fund manager of Miton UK MicroCap Trust, discusses navigating the economic landscape and standout companies in 2024. Find out more here. #investment #microcap
Accrol Group Holdings plc has reported strong H1 FY24 results, with impressive growth in adjusted EBITDA and adjusted PBT. The company remains on track to meet expectations and has seen gains in market share. Furthermore, the private label segment of the UK tissue market continues to increase, and the sales of biodegradable wet wipes have been exceptionally strong. Accrol's outlook remains positive with expected further volume growth.
Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.

Search

Search